Skip to content
My WebMD Sign In, Sign Up

Osteoporosis Health Center

Font Size

Osteoporosis: On the Cutting Edge of Bone Health

Advances in research are changing the way osteoporosis experts think about this widespread disease.

New Osteoporosis Treatments continued...

The identification of the high bone mass gene and the chemical signaling pathway it involves has opened up a wide range of new possibilities for osteoporosis treatment. "The prospect here is to build an osteoporosis drug or drugs that cause the body to act as if it has that mutation, building up more bone," says Heaney. He believes that drugs aimed at this pathway are already in human testing, but it may take some time before they can come to market. "Because this pathway acts on other areas of the body besides bone, you have to be sure that your drug isn't producing unintended results elsewhere."

Scientists are also investigating new compounds, called vitamin D analogs, as potential osteoporosis treatments. These drugs are, essentially, a supercharged version of vitamin D supplements -- molecules that have been altered, based on vitamin D's structure, to minimize bone loss and maximize bone formation.

One of these drugs, 2MD, has shown great promise in animal models of osteoporosis, and is now being studied in humans. "It dramatically stimulates bone formation, and if we are able to see anything that even vaguely approximates the same kind of results in humans, this is going to be huge," says Neil Binkley, MD, co-director of the Osteoporosis Clinical Center and Research Program at the University of Wisconsin-Madison. Another plus: because the drug is based on vitamin D, Binkley predicts that there may not be any unusual side effects, and it may even boost the immune system's function the way that natural vitamin D does.

One drug that is closer to approval is an experimental treatment called denosumab. This twice-yearly injection is now in Phase III clinical trials, and has been shown to improve bone density. Denosumab is aimed at an entirely new target for osteoporosis: a protein called RANK ligand. This protein plays a key role in the process by which cells called osteoclasts break down bone. And researchers hope the drug will help keep the process of bone loss in check with bone replacement. Denosumab could be on the market as soon as late 2008.

"Osteoporosis is a fairly young field," says Binkley. "When I was in medical school, you diagnosed osteoporosis only after someone broke a bone, just as we used to only diagnose heart disease after a heart attack. We know more now, and we're developing better tools to diagnose, treat, and prevent osteoporosis."

1|2|3
Reviewed on December 04, 2009

Today on WebMD

Women working out and walking with weights
Reduce bone loss and build stronger muscles.
Chinese cabbage
Calcium-rich foods to add to your diet.
 
woman stretching
Get the facts on osteoporosis.
Porous bone
Causes, symptoms, risk factors, and treatment.
 
Lactose Intolerance
Article
Woman holding plate of brocolli
Article
 
Dairy products
Tool
Superfood for Bones
Slideshow
 
Screening Tests for Women
Slideshow
exercise endometrial cancer
Article
 
hand holding medicine
Article
Working Out With Osteoporosis
Video